[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Techne Corp 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 USA

www.bio-techne.com Employees: 3,100 P: 612-379-8854 F: 612-656-4400

Sector:

Medical

Description:

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 11,163,370
Enterprise Value, $K 11,347,180
Shares Outstanding, K 156,569
Float, K 154,534
% Float 98.70%
Short Interest, K 18,204
Short Float 11.63%
Days to Cover 6.16
Short Volume Ratio 0.13
% of Insider Shareholders 1.30%
% of Institutional Shareholders 98.95%

Financials:

Annual Sales, $ 1,220 M
Annual Net Income, $ 73,400 K
Last Quarter Sales, $ 311,420 K
Last Quarter Net Income, $ 51,050 K
EBIT, $ 153,760 K
EBITDA, $ 263,660 K

Growth:

1-Year Return 31.04%
3-Year Return -15.34%
5-Year Return -37.82%
5-Year Revenue Growth 65.11%
5-Year Earnings Growth 76.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.53 on 05/06/26
Next Earnings Date 08/05/26 [--]
Earnings Per Share ttm 1.74
EPS Growth vs. Prev Qtr 23.08%
EPS Growth vs. Prev Year -4.00%
Annual Dividend & Yield (Paid) 0.32 (0.45%)
Annual Dividend & Yield (Fwd) 0.32 (0.45%)
Most Recent Dividend 0.080 on 05/18/26
Next Ex-Dividends Date 05/18/26
Dividend Payable Date 05/29/26
Dividend Payout Ratio 18.49%
Most Recent Split 4-1 on 11/30/22

TECH Ratios

Ratio
Price/Earnings ttm 40.89
Price/Earnings forward 40.43
Price/Earnings to Growth 8.48
Return-on-Equity % 13.57%
Return-on-Assets % 10.66%
Profit Margin % 6.02%
Debt/Equity 0.10
Price/Sales 9.24
Price/Cash Flow 29.10
Price/Book 5.34
Book Value/Share 13.32
Interest Coverage 12.57
60-Month Beta 1.29

TECH Dividends

Date Value
05/18/26 $0.0800
02/13/26 $0.0800
11/17/25 $0.0800
08/18/25 $0.0800
05/19/25 $0.0800
02/14/25 $0.0800
11/08/24 $0.0800
08/19/24 $0.0800
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.